See if EPZICOM is an option for you
EPZICOM contains abacavir, which is also contained in ZIAGEN® (abacavir sulfate) and TRIZIVIR® (abacavir sulfate, lamivudine, and zidovudine). Patients taking EPZICOM may have a serious allergic reaction (hypersensitivity reaction) that can cause death. Your risk of this allergic reaction is much higher if you have a gene variation called HLA-B*5701 than if you do not.
(See Bolded Warning). CONTINUED BELOW
EPZICOM is a prescription medicine used to treat HIV infection. EPZICOM includes two medicines: abacavir sulfate (ZIAGEN®) and lamivudine, or 3TC (EPIVIR®). Both of these medicines are called nucleoside analogue reverse transcriptase inhibitors (NRTIs). When used together in combination with other antiviral agents, they help lower the amount of HIV in your blood. This helps to keep your immune system as healthy as possible so that it can help fight infection.
Different combinations of medicines are used to treat HIV infection. You and your healthcare provider should discuss which combination of medicines is best for you.
Do not take EPZICOM if you:
Before starting EPZICOM, tell your healthcare provider about all of your medical conditions, including if you:
Tell your healthcare provider about all the medicines you take, including prescription and nonprescription medicines, vitamins, and herbal supplements. Especially tell your healthcare provider if you take any of the following medicines:
Avoid doing things that can spread HIV infection, as EPZICOM does not stop you from passing the HIV infection to others.
EPZICOM can cause the following serious side effects:
Some HIV medicines, including EPZICOM, may increase your risk of heart attack. If you have heart problems, smoke, or suffer from diseases that increase your risk of heart disease such as high blood pressure, high cholesterol, or diabetes, tell your healthcare provider.
The most common side effects with EPZICOM are trouble sleeping, depression, headache, tiredness, dizziness, nausea, diarrhea, rash, fever, stomach pain, abnormal dreams, and anxiety. Most of these side effects did not cause people to stop taking EPZICOM.
This list of side effects is not complete. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
General information for safe and effective use of EPZICOM
Medicines are sometimes prescribed for conditions that are not mentioned in Medication Guides. Do not use EPZICOM for a condition for which it was not prescribed. Do not give EPZICOM to other people, even if they have the same symptoms that you have. It may harm them.
This is a summary of the most important information about EPZICOM. If you would like more information, talk with your healthcare provider. You can ask your healthcare provider or pharmacist for the information that is written for healthcare professionals, or call 1-888-825-5249.
Active ingredients: abacavir sulfate and lamivudine
Inactive ingredients: Each film-coated EPZICOM Tablet contains the inactive ingredients magnesium stearate, microcrystalline cellulose, and sodium starch glycolate. The tablets are coated with a film (OPADRY® orange YS-1-13065-A) that is made of FD&C Yellow No. 6, hypromellose, polyethylene glycol 400, polysorbate 80, and titanium dioxide.
HIVID (zalcitabine) is a registered trademark of Roche Pharmaceuticals.
Opadry is a registered trademark of BPSI Holdings LLC.
As with all medicines, you may experience side effects while taking EPZICOM. The most common include:
You can find more information about side effects in Is EPZICOM an Option for You?. Also, if you experience any side effects while taking EPZICOM, please contact your doctor.
However, before you start taking EPZICOM, your doctor will do a blood test to prescreen you for an allergic reaction to abacavir. The blood test will check if you have the HLA-B*5701 genetic variation. Patients who test negative for HLA-B*5701 may develop an allergic reaction to EPZICOM; however this occurs significantly less frequently than in patients who test positive for HLA-B*5701.
Our ViiV Patient Savings Card, depending upon your eligibility (restrictions apply), may be able to help you save on our prescription medicines, like EPZICOM. Learn more information about the ViiV Patient Savings Card.
If you have questions about ViiV Healthcare savings offers or any of the other patient assistance programs, please call us toll-free at 1-877-ViiV-USA (1-877-844-8872). Trained staff members are available weekdays from 8 a.m. to 8 p.m. Eastern time to take your call.
By prescription only.
Important Safety Information
EPZICOM contains abacavir, which is also contained in ZIAGEN® (abacavir sulfate) and TRIZIVIR® (abacavir sulfate, lamivudine, and zidovudine). Patients taking EPZICOM may have a serious allergic reaction (hypersensitivity reaction) that can cause death. Your risk of this allergic reaction is much higher if you have a gene variation called HLA-B*5701 than if you do not. Your doctor can determine with a blood test if you have this gene variation. If you get a symptom from 2 or more of the following groups while taking EPZICOM, call your doctor right away to determine if you should stop taking this medicine.
Carefully read the Warning Card that your pharmacist gives you and carry it with you at all times.
If you stop EPZICOM because of an allergic reaction, NEVER take EPZICOM (abacavir sulfate and lamivudine) or any other abacavir-containing medicine (ZIAGEN and TRIZIVIR) again. If you take EPZICOM or any other abacavir-containing medicine again after you have had an allergic reaction, WITHIN HOURS you may get life-threatening symptoms that may include very low blood pressure or death.
If you stop EPZICOM for any other reason, even for a few days, and you are not allergic to EPZICOM, talk with your healthcare provider before taking it again. Taking EPZICOM again can cause a serious allergic or life-threatening reaction, even if you never had an allergic reaction before. If your healthcare provider tells you that you can take EPZICOM again, start taking it when you are around medical help or people who can call a healthcare provider if you need one.
A buildup of lactic acid in the blood and an enlarged liver, including fatal cases, have been reported.
Do not take EPZICOM if your liver does not function normally.
Some patients infected with both hepatitis B virus (HBV) and HIV have worsening of hepatitis after stopping lamivudine (a component of EPZICOM). Discuss any change in treatment with your healthcare provider. If you have both HBV and HIV and stop treatment with EPZICOM, you should be closely monitored by your healthcare provider for at least several months.
Worsening of liver disease (sometimes resulting in death) has occurred in patients infected with both HIV and hepatitis C virus who are taking anti-HIV medicines and are also being treated for hepatitis C with interferon with or without ribavirin. If you are taking EPZICOM as well as interferon with or without ribavirin and you experience side effects, be sure to tell your healthcare provider.
When you start taking HIV medicines, your immune system may get stronger and could begin to fight infections that have been hidden in your body, such as pneumonia, herpes virus, or tuberculosis. If you have new symptoms after starting your HIV medicines, be sure to tell your healthcare provider.
Changes in body fat may occur in some patients taking antiretroviral therapy. These changes may include an increased amount of fat in the upper back and neck ("buffalo hump"), breast, and around the trunk. Loss of fat from the legs, arms, and face may also occur. The cause and long-term health effects of these conditions are not known at this time.
Some HIV medicines, including those containing abacavir (ZIAGEN, EPZICOM, and TRIZIVIR), may increase your risk of heart attack. If you have heart problems, smoke, or suffer from diseases that increase your risk of heart disease such as high blood pressure, high cholesterol, or diabetes, tell your healthcare provider.
The most common side effects seen with the drugs in EPZICOM dosed once-daily were allergic reaction, trouble sleeping, depression, headache, tiredness, dizziness, nausea, diarrhea, rash, fever, stomach pain, abnormal dreams, and anxiety. Most of these side effects did not cause people to stop taking EPZICOM.